Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Total Liabilities 2009–2025
Neurocrine Biosciences Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Neurocrine Biosciences Inc. total liabilities as of December 31, 2025: 1.38B, a 22.09% increase year-over-year.
- Neurocrine Biosciences Inc. total liabilities for 2025 were 1.38B, a 22.09% increase from 2024.
- Neurocrine Biosciences Inc. total liabilities for 2024 were 1.13B, a 10.75% increase from 2023.
- Neurocrine Biosciences Inc. total liabilities for 2023 were 1.02B, a 54.24% increase from 2022.
- Neurocrine Biosciences Inc. total liabilities for 2022 were 660.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Neurocrine Biosciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,378 |
| 2024 | $1,129 |
| 2023 | $1,019 |
| 2022 | $661 |
| 2021 | $699 |
| 2020 | $609 |
| 2019 | $669 |
| 2018 | $512 |
| 2017 | $445 |
| 2016 | $50 |
| 2015 | $50 |
| 2014 | $34 |
| 2013 | $34 |
| 2012 | $42 |
| 2011 | $78 |
Neurocrine Biosciences Inc. Total Liabilities — FAQ
Neurocrine Biosciences Inc. (NBIX) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's total liabilities history?
The chart and table above show Neurocrine Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.